ANAB – Welcome to stockcalc’s blog archive. We’ve launched a new blog! Visit us here.

Intercept Pharmaceuticals (ICPT:NAS) Fundamental Valuation Report

By admin Posted on May 3, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Intercept Pharmaceuticals(ICPT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$19.78 (USD) 04/30/2021 Weighted Valuation$10.32 (USD) Overall RatingOvervalued by 47.8% Valuation Models Comparables: $10.32 (USD) Valuation Methods …

Intercept Pharmaceuticals (ICPT:NAS) Fundamental Valuation Report Read more »

AnaptysBio (ANAB:NAS) Fundamental Valuation Report

By admin Posted on April 19, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report AnaptysBio(ANAB:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$22.07 (USD) 04/15/2021 Weighted Valuation$29.03 (USD) Overall RatingUndervalued by 31.6% Valuation Models Comparables: $35.39 (USD) Adjusted Book Value: $35.72 …

AnaptysBio (ANAB:NAS) Fundamental Valuation Report Read more »

athenahealth (ATHN:NAS) and New York Community Banc (NYCB:NYS) Upgraded

By Brian Donovan Posted on August 30, 2018 Posted in Upgraded Stocks

Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …

athenahealth (ATHN:NAS) and New York Community Banc (NYCB:NYS) Upgraded Read more »

Tag: ANAB

Intercept Pharmaceuticals (ICPT:NAS) Fundamental Valuation Report

AnaptysBio (ANAB:NAS) Fundamental Valuation Report

athenahealth (ATHN:NAS) and New York Community Banc (NYCB:NYS) Upgraded